World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ChiCTR
Last refreshed on: 18 April 2017
Main ID:  ChiCTR-IOR-17011150
Date of registration: 2017-04-16
Prospective Registration: Yes
Primary sponsor: The First Affiliated Hospital of Wenzhou Medical University
Public title: Sufentanyl improves the analgesia effect of continuous femoral nerve block after total knee arthroplasty
Scientific title: Sufentanyl improves the analgesia effect of continuous femoral nerve block after total knee arthroplasty
Date of first enrolment: 2017-04-17
Target sample size: Group SR:30;Group R:30;
Recruitment status: Recruiting
URL:  http://www.chictr.org.cn/showproj.aspx?proj=18663
Study type:  Interventional study
Study design:  Randomized parallel controlled trial  
Phase:  Other
Countries of recruitment
China
Contacts
Name: Quanguang Wang   
Address:  Shangcai Villiage, Nanbaixiang Street, Ouhai District, Wenzhou, Zhejiang
Telephone: +86 13736935500
Email: quanguangwang@sina.com
Affiliation:  The First Affiliated Hospital of Wenzhou Medical University
Name: Fangfang Xia   
Address:  Shangcai Villiage, Nanbaixiang Street, Ouhai District, Wenzhou, Zhejiang
Telephone: +86 13806622872
Email: helenxia4271@163.com
Affiliation:  The First Affiliated Hospital of Wenzhou Medical University
Key inclusion & exclusion criteria
Inclusion criteria: patients scheduled for bilateral total knee arthroplasty were included into the study, aged 53~82years, weight 47~81kg, height 150~179cm, ASA I or II.
Exclusion criteria: Exclusion of neurologic or neuromuscular disease, allergy to local anesthetics, chronic opiate usage or unlikely to be fully cooperative during the study, such as having psychiatric disorders

Age minimum: 53
Age maximum: 82
Gender: Both
Health Condition(s) or Problem(s) studied
total knee arthroplasty
Intervention(s)
Group SR:0.2% ropivacaine plus sufentanyl;Group R:0.2% ropivacaine;
Primary Outcome(s)
The intensity of postoperative pain of bilateral lower limbs;
Secondary Outcome(s)
patients’ degree of satisfaction about the analgesia of each side of the lower limb;The numbers of patients wakening up because of each side of the lower limb pain;the amount given by PCA;
Secondary ID(s)
Source(s) of Monetary Support
self-financing
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history